153
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Prognostic factors in pediatric pneumococcal meningitis patients in mainland China: a retrospective multicenter study

, , , , , , , , , & show all
Pages 1501-1512 | Published online: 07 Jun 2019

References

  • Nuoh RD, Nyarko KM, Nortey P, et al. Review of meningitis surveillance data, upper West Region, Ghana 2009-2013. Pan Afr Med J. 2016;25(Suppl 1):9.
  • Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–2025. doi:10.1056/NEJMoa100799421612470
  • Xie Y, Tan Y, Chongsuvivatwong V, et al. A population-based acute meningitis and encephalitis syndromes surveillance in Guangxi, China, May 2007-June 2012. PLoS One. 2015;10(12):e0144366. doi:10.1371/journal.pone.014436626633824
  • Davis LE. Acute bacterial meningitis. Continuum (Minneap Minn). 2018;24(5, Neuroinfectious Disease):1264–1283.30273239
  • Buchholz G, Koedel U, Pfister HW, Kastenbauer S, Klein M. Dramatic reduction of mortality in pneumococcal meningitis. Crit Care. 2016;20(1):312. doi:10.1186/s13054-016-1362-x27716447
  • Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339–347. doi:10.1016/S1473-3099(16)30197-926652862
  • McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T. Acute bacterial meningitis in adults. Lancet. 2016;388(10063):3036–3047. doi:10.1016/S0140-6736(16)30654-727265346
  • Hasbun R, Rosenthal N, Balada-Llasat JM, et al. Epidemiology of meningitis and encephalitis in the United States, 2011-2014. Clin Infect Dis. 2017;65(3):359–363. doi:10.1093/cid/cix47428419350
  • Stockmann C, Ampofo K, Byington CL, et al. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics. 2013;132(3):421–428. doi:10.1542/peds.2013-062123979090
  • O‘Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902. doi:10.1016/S0140-6736(09)61069-219748398
  • Gil Prieto R, San Roman Montero J, Gomez Alejandre C, Alvaro Meca LA, Rivero A, Gil de Miguel A. Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998–2006). Vaccine. 2009;27(20):2669–2673.19428877
  • Levy C, Varon E, Picard C, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J. 2014;33(12):1216–1221. doi:10.1097/INF.000000000000030925037044
  • Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/S0140-6736(14)61682-225530442
  • Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Infect. 2016;73(1):18–27. doi:10.1016/j.jinf.2016.04.00927105658
  • Dorsett M, Liang SY. Diagnosis and treatment of central nervous system infections in the emergency department. Emerg Med Clin North Am. 2016;34(4):917–942. doi:10.1016/j.emc.2016.06.01327741995
  • Erdem H, Elaldi N, Oztoprak N, et al. Mortality indicators in pneumococcal meningitis: therapeutic implications. Int J Infect Dis. 2014;19:13–19. doi:10.1016/j.ijid.2013.09.01224211227
  • Jordan I, Calzada Y, Monfort L, et al. Clinical, biochemical and microbiological factors associated with the prognosis of pneumococcal meningitis in children. Enferm Infecc Microbiol Clin. 2016;34(2):101–107. doi:10.1016/j.eimc.2015.03.00425998267
  • Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;(9):CD004405.26362566
  • Chao YN, Chiu NC, Huang FY. Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect. 2008;41(1):48–53.18327426
  • Pagliano P, Fusco U, Attanasio V, et al. Pneumococcal meningitis in childhood: a longitudinal prospective study. FEMS Immunol Med Microbiol. 2007;51(3):488–495. doi:10.1111/j.1574-695X.2007.00324.x17877732
  • Irene Koomen DE, Grobbee JJ, Roord RD, Jennekens-Schinkel A, Van Furth AM. Hearing loss at school age in survivors of bacterial meningitis_ assessment,incidence, and prediction. Pediatrics. 2003;112(5):1049–1053. doi:10.1542/peds.112.5.104914595044
  • McIntyre PB, Macintyre CR, Gilmour R, Wang H. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child. 2005;90(4):391–396. doi:10.1136/adc.2004.05533515781931
  • Kaplan SL, Goddard J, Van Kleeck M, Catlin FI, Rd. F. Ataxia and deafness in children due to bacterial meningitis. Pediatrics. 1981;68(1):8–13.7243512
  • Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol. 2006;60(4):456–468. doi:10.1002/ana.2094416958121
  • Kornelisse RF, Westerbeek CML, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis. 1995;21(6):1390–1397. doi:10.1093/clinids/21.6.13908749621
  • Selva L, Ciruela P, Esteva C, et al. Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis. 2012;31(7):1487–1495. doi:10.1007/s10096-011-1468-722052607
  • Arditi M, Mason EO, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102(5):1087–1097.9794939
  • Buckingham SC, McCullers JA, Luján-Zilbermann J, Knapp KM, Orman KL, English BK. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis. Pediatrics. 2006;117(5):1688–1694. doi:10.1542/peds.2005-228216651325
  • Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12(5):389–394. doi:10.1097/00006454-199305000-000088327300
  • Ciapponi A, Elorriaga N, Rojas JI, et al. Epidemiology of pediatric pneumococcal meningitis and bacteremia in Latin America and the caribbean: a systematic review and meta-analysis. Pediatr Infect Dis J. 2014;33(9):971–978. doi:10.1097/INF.000000000000030924830699
  • Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006;5(2):123–129. doi:10.1016/S1474-4422(05)70288-X16426988
  • Hoen B, Viel JF, Gérard A, Dureux JB, Canton P. Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors. Eur J Med. 1993;2(1):28–32.8258002
  • Auburtin M, Porcher R, Bruneel F, et al. Pneumococcal meningitis in the intensive care unit prognostic factors of clinicaloutcome in a series of 80 cases. Am J Respir Crit Care Med. 2002;165(5):713–717. doi:10.1164/ajrccm.165.8.210610411874820
  • Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126(5):1015–1025. doi:10.1093/brain/awg11312690042
  • Low PS, Lee BW, Yap HK, et al. Inflammatory response in bacterial meningitis: cytokine levels in the cerebrospinal fluid. Ann Trop Paediatr. 1995;15(1):55–59.7598438
  • Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24(3):557–591.21734248
  • Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010;10(1):32–42. doi:10.1016/S1473-3099(09)70306-820129147
  • Barichello T, Fagundes GD, Generoso JS, Elias SG, Simoes LR, Teixeira AL. Pathophysiology of neonatal acute bacterial meningitis. J Med Microbiol. 2013;62(Pt 12):1781–1789. doi:10.1099/jmm.0.059840-023946474